ClinicalTrials.Veeva

Menu

Gonadal Function in Young to Middle Aged HIV-infected Men

A

Azienda Ospedaliero-Universitaria di Modena

Status

Completed

Conditions

Human Immunodeficiency Virus
Erectile Dysfunction
Hypogonadism, Male

Treatments

Other: No intervention is provided

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

HIV infection is associated to premature decline of serum testosterone. However, prevalence and biochemical characterization of hypogonadism in HIV-infected men are still to be well defined. HIV-infection is strongly associated to erectile dysfunction in men, but preliminary data suggest that it is poorly associated with serum testosterone in this context.

Full description

The aim of this study is to evaluate the gonadal function of young to middle aged HIV-infected men in order to characterize hypogonadism by assessing circulating total testosterone with either Liquid Chromatography tandem Mass Spectrometry (LC-MS/MS) or chemiluminescent immunoassay. Furthermore, secondary aim is to assess the erectile function through the use of validated questionnaires (International Index of Erectile Function (IIEF) 15 and 5).

Enrollment

315 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male gender
  • Age 18-50 years
  • HIV-infection
  • Ongoing Highly Active Antiretroviral Therapy

Exclusion criteria

  • Previous treatment with androgens, anti-androgens
  • Severe liver insufficiency
  • Severe renal insufficiency

Trial design

315 participants in 1 patient group

HIV-infected male patients
Description:
Male patients (age 18-50 years) with HIV-infection and ongoing HAART therapy No intervention is provided
Treatment:
Other: No intervention is provided

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems